Treatments
The French Coagulation Market, 2009-2018
| Publication Date | September 2009 |
| Publisher | Venture Planning Grp. |
| Product Type | Report |
| Pages | 400 |
| ISBN Number | not applicable |
| Product Code | VEP00144 |
Summary
This report presents a comprehensive analysis of the French coagulation market, including:
- Major issues pertaining to the French coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 coagulation procedures performed in French hospitals and commercial laboratories, including typical coagulation daily work loads.
- Placement estimates for major automated and semiautomated systems.
- Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
- Ten-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of coagulation technologies and their potential market applications.
- Major opportunities for coagulation instruments and consumables.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contents
- Worldwide Market and Technology Overview
- A. Major Routine and Special Coagulation Tests
- 1. Introduction
- 2. Activated Clotting Time (ACT)
- 3. Activated Protein C Resistance
- 4. Activated PTT (APTT)
- 5. Alpha-2 Antiplasmin
- 6. Antithrombin III
- 7. Bleeding Time
- 8. D-Dimer
- 9. Factor Assays
- a. Introduction
- b. Factor II
- c. Factor V
- d. Factor V Leiden
- e. Factor VII
- f. Factor VIII
- g. Factor IX
- h. Factor IXa
- i. Factor X (Stuart Factor)
- j. Factor Xa
- k. Factor XI
- l. Factor XII
- m. Factor XIII
- 10. Fibrin Degradation Products
- 11. Fibrinogen
- 12. Fletcher Factor/Pre-Kallikrein Factor Activation
- 13. Heparin/Anti-Factor Xa
- 14. Heparin-Induced Thrombocytopenia
- 15. Plasmin
- 16. Plasminogen
- 17. Plasminogen Activator Inhibitor
- 18. Platelet Function/Aggregation
- 19. Protein C
- 20. Proteins S
- 21. Prothrombin Mutation
- 22. Prothrombin Time (PT)
- 23. Reptilase Time
- 24. Thrombin Time
- 25. Von Willebrand's Factor Fav/Ag
- B. Instrumentation Review
- Introduction
- Amelung/Sigma Amax CS190
- Amelung/Sigma Amax CS400
- Amelung/Sigma KC 40, 4A, 1A Series
- Benk Hemolab
- Benk TRT Thrombotimer
- Bio/Data MCA 310
- Bio/Data PAP-4C D/4D/4C
- Cardiovascular Diagnostics COAG
- Dade Behring BCS
- Dade Behring BCT
- Dade Behring BF II/Fibrintimer Series
- Diagnostica Stago STA-R
- Diagnostica Stago STA Compact
- Diagnostica Stago Star 4/8
- Helena THOR
- Helena Laboratories Cascade 480
- Helena Laboratories PACKS-4
- Helena Laboratories Cascade M
- Instrumentation Laboratory ACL9000
- Instrumentation Laboratory ACL7000
- Instrumentation Laboratory ACL6000
- Instrumentation Laboratory Futura
- Instrumentation Laboratory ACL 100 and 1000 series
- Instrumentation Laboratory Electra 1800C
- Instrumentation Laboratory Electra 1600/C
- Instrumentation LaboratoryElectra 1400C
- Instrumentation Laboratory Electra 1000C
- ITC Hemochron 8000
- Organon Teknika Coag-A-Mate Max
- Organon Teknika MDA 180
- Organon Teknika Coag-A-Mate MTX
- Organon Teknika Coag-A-Mate XC/Plus
- Organon Teknika Coag-A-Mate RA4
- Organon Teknika Coag-A-Mate XM
- Roche Diagnostics CoaguChek
- Sysmex CA-1500
- Sysmex CA-7000
- Sysmex CA-6000
- Sysmex CA-500
- Sysmex CA-50
- Sysmex CA-5000/CA-1000
- Teco Coatron II/Jr./AccuStasis 5000
- C. Major in Vitro Diagnostic Technologies And Their Potential Applications
- 1. Chromogenic Substrates
- 2. Monoclonal and Polyclonal Antibodies
- 3. Immunoassays
- a. Applications
- b. Technological Principle
- c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
- d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
- e. Latex Agglutination
- f. Immunoprecipitation
- 4. Microcomputers
- 5. Automation
- 6. Robotics
- 7. DNA Probes
- a. Overview
- b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
- 8. Artificial Intelligence
- 9. Dry Chemistry
- 10. Biosensors
- D. Worldwide Market Overview
- 1. Business Environment
- 2. Market Structure
- 3. Market Size and Growth
- France
- A. Executive Summary
- B. Business Environment
- C. Market Structure
- D. Market Size, Growth and Major Suppliers
- Major Product Development Opportunities
- Design Criteria for Decentralized Testing Products
- Alternative Market Penetration Strategies
- A. Internal Development
- B. Collaborative Arrangements
- C. University Contracts
- D. Distribution Strategies for Decentralized Testing Markets
- 1. Marketing Approaches
- 2. Product Complexity
- 3. Customer Preference
- 4. Established Suppliers
- 5. Emerging Suppliers
- 6. Major Types Of Distributors
- 7. Market Segmentation
- Potential Market Entry Barriers and Risks
- A. Market Maturity
- B. Cost Containment
- C. Competition
- D. Technological Edge and Limitations
- E. Patent Protection
- F. Regulatory Constraints
- G. Decentralized Testing Market Challenges
- Competitive Assessments
- Abbott
- Agen Biomedical
- American Diagnostica
- American Labor
- Axis-Shield
- Beckman Coulter
- Becton Dickinson
- Biosite
- Chronolog
- Corgenix Medical
- Diagen
- Diagnostica Stago
- Helena Laboratories
- HemoSense/Inverness Medical Innovations
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Medafor
- Nanogen
- Roche
- Sarstedt
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- Trinity Biotech
- ZyCare
- Appendixes
- Appendix I: Major Companies Developing or
- Marketing Coagulation Analyzers
- Appendix II: Major Companies Developing or
- Marketing Coagulation Calibrators and Controls
- Appendix III: Major Companies Developing or
- Marketing Platelet Aggregometers
- Appendix IV: Assumed Currency Exchange Rates
- Major Companies Developing or Marketing Activated Clotting Time Tests
- Major Companies Developing or Marketing APTT Tests
- Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
- Major Companies Developing or Marketing Antithrombin III Tests
- Major Companies Developing or Marketing Bleeding Time Tests
- Major Companies Developing or Marketing D-dimer Tests
- Major Companies Developing or Marketing Factor Assays
- Major Companies Developing or Marketing Fibrin Degradation Product Tests
- Major Companies Developing or Marketing Fibrinogen Tests
- Major Companies Developing or Marketing Heparin Tests
- Major Companies Developing or Marketing Plasmin Tests
- Major Companies Developing or Marketing Plasminogen Tests
- Major Companies Developing or Marketing Plasminogen ActivatorInhibitor Tests
- Major Companies Developing or Marketing Platelet Aggregation Tests
- Major Companies Developing or Marketing Protein C Tests
- Major Companies Developing or Marketing Protein S Tests
- Major Companies Developing or Marketing PT Tests
- Major Companies Developing or Marketing Thrombin Time Tests
- Major Companies Developing or Marketing TPA Tests
- Major Companies Developing or Marketing Von Willebrand's Factor Tests
- Worldwide, All Market Segments, Laboratories Performing Coagulation Tests By Country, 2008
- Worldwide, All Market Segments, Total Coagulation Test Volume By Country, 2008-2018
- Worldwide, All Market Segments, Total Coagulation Reagent Market By Country, 2008-2018
- Worldwide, All Market Segments, Total Coagulation Instrument Market By Country, 2008-2018
- Worldwide, All Market Segments, Total Coagulation Diagnostics Market By Country, 2008-2018
- Executive Summary Table: France, Total Coagulation Diagnostics
- Market By Market Segment and Product Category, 2008-2018
- France, Laboratories Performing Coagulation Tests By Market Segment, 2008
- France, Hospital Laboratories Performing Coagulation Tests By Bed Size, 2008
- France, Commercial/Private Laboratories Performing Coagulation
- Tests By Annual Test Volume, 2008
- France, Hospital Laboratories Average Daily Test Volume, 2008
- France, Commercial/Private Laboratories Average Daily Test Volume, 2008
- France, Total Coagulation Test Volume By Market Segment,2008-2018
- France, All Market Segments Coagulation Test Volume,2008-2018
- France, Hospital Laboratories Coagulation Test Volume,2008-2018
- France, Commercial/Private Laboratories Coagulation Test Volume,2008-2018
- France, Coagulation Reagent Market By Market Segment,2008-2018
- France, Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2008
- France, Coagulation Instrument Market By Market Segment,2008-2018
- France, Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2008
- France, Major Suppliers of Coagulation Analyzers, Estimated
- Placements and Installed Base By Supplier and Model, 2008
- France, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2008
- France, Total Coagulation Diagnostics Market By Product Category, 2008-2018
- France, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2008







